Skip to content

The observational study to evaluate the prognostic value of malignancies in patients with COVID-19 from Japanese registry database of COVID-19.

The observational study of COVID-19 patients with cancer from Japanese registry database of COVID-19. - The observational study of COVID-19 patients with cancer from Japanese registry database of COVID-19.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044597
Enrollment
31364
Registered
2021-06-20
Start date
2021-04-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 and cancer

Interventions

None listed

Sponsors

Matsusaka Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who were enrolled in COVIREGI-JP.

Exclusion criteria

Exclusion criteria: 1. The patients with missing data about survival information or cancer. 2. The patients who missed the essential data to be analyzed among other clinical data.

Design outcomes

Primary

MeasureTime frame
Mortality rate in the COVID-19 patients with cancer.

Countries

Japan

Contacts

Public ContactKentaro Ito

Matsusaka Municipal Hospital Respiratory Center

kentarou_i_0214@yahoo.co.jp0598231515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026